Resultats de la cerca - Chen-Sheng Lin

  • Mostrar 1 - 6 resultats de 6
Refinar resultats
  1. 1
    Retrospective Evaluation of Serum Markers APRI and AST/ALT for Assessing Liver Fibrosis and Cirrhosis in Chronic Hepatitis B and C Patients with Hepatocellular Carcinoma

    Retrospective Evaluation of Serum Markers APRI and AST/ALT for Assessing Liver Fibrosis and Cirrhosis in Chronic Hepatitis B and C Patients with Hepatocellular Carcinoma per Chen‐Sheng Lin, Chi‐Sen Chang, Sheng‐Shun Yang, Hong‐Zen Yeh, Cheng‐Wen Lin

    Publicat 2008
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  2. 2
    Endophilin-A2-mediated endocytic pathway is critical for enterovirus 71 entry into caco-2 cells

    Endophilin-A2-mediated endocytic pathway is critical for enterovirus 71 entry into caco-2 cells per Chen, Sheng-Lin, Liu, Yan-Gang, Zhou, Yong-Tao, Zhao, Ping, Ren, Hao, Xiao, Man, Zhu, Yong-Zhe, Qi, Zhong-Tian

    Publicat 2019
    Obtenir text complet Obtenir text complet Obtenir text complet
    Text
    Afegir a favorits
    Guardat en:
  3. 3
    Epidemiology of human coronavirus NL63 infection among hospitalized patients with pneumonia in Taiwan

    Epidemiology of human coronavirus NL63 infection among hospitalized patients with pneumonia in Taiwan per Su‐Hua Huang, Mei-Chi Su, Ni Tien, Chien-Jhen Huang, Yu‐Ching Lan, Chen-Sheng Lin, Chao-Hsien Chen, Cheng‐Wen Lin

    Publicat 2015
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  4. 4
    Antiviral activity of Sambucus FormosanaNakai ethanol extract and related phenolic acid constituents against human coronavirus NL63

    Antiviral activity of Sambucus FormosanaNakai ethanol extract and related phenolic acid constituents against human coronavirus NL63 per Jing‐Ru Weng, Chen-Sheng Lin, Hsueh‐Chou Lai, Yu-Ping Lin, Ching-Ying Wang, Yu‐Chi Tsai, Kun-Chang Wu, Su‐Hua Huang, Cheng‐Wen Lin

    Publicat 2019
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  5. 5
    Nivolumab monotherapy in recurrent metastatic urothelial carcinoma (CheckMate 032): a multicentre, open-label, two-stage, multi-arm, phase 1/2 trial

    Nivolumab monotherapy in recurrent metastatic urothelial carcinoma (CheckMate 032): a multicentre, open-label, two-stage, multi-arm, phase 1/2 trial per Padmanee Sharma, Margaret K. Callahan, Petri Bono, Joseph W. Kim, Pavlina Spiliopoulou, Emiliano Calvo, Rathi N. Pillai, Patrick A. Ott, Filippo de Braud, Michael A. Morse, Dung T. Le, Dirk Jaeger, Emily Chan, Chris Harbison, Chen-Sheng Lin, Marina Tschaika, Alex Azrilevich, Jonathan E. Rosenberg

    Publicat 2016
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  6. 6
    Nivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (CheckMate 032): a multicentre, open-label, phase 1/2 trial

    Nivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (CheckMate 032): a multicentre, open-label, phase 1/2 trial per Scott Antonia, José A. López-Martín, Johanna C. Bendell, Patrick A. Ott, Matthew H. Taylor, Joseph P. Eder, Dirk Jäger, M. Catherine Pietanza, Dung T. Le, Filippo de Braud, Michael A. Morse, Paolo A. Ascierto, Leora Horn, Asim Amin, Rathi N. Pillai, Jonathan J. Evans, Ian Chau, Petri Bono, Akin Atmaca, Padmanee Sharma, Christopher Harbison, Chen-Sheng Lin, Olaf Christensen, Emiliano Calvo

    Publicat 2016
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:

Eines de cerca: